Yayın:
The effects of exenatide and insulin glargine treatments on bone turnover markers and bone mineral density in postmenopausal patients with type 2 diabetes mellitus

Sadeleştirilmiş öğe sayfası
dc.contributor.authorTarkun, İlhan
dc.contributor.authorZeynep Cantürk
dc.contributor.authorAlev Selek
dc.contributor.authorBerrin Çetinarslan
dc.contributor.authorİlhan Tarkun
dc.contributor.authorYağmur Çakmak
dc.contributor.authorCanan Baydemır
dc.contributor.orcid0000-0003-4608-4433
dc.contributor.orcid0000-0001-7114-2565
dc.contributor.orcid0000-0002-0646-8697
dc.contributor.orcid0000-0002-8041-8161
dc.contributor.orcid0000-0002-3529-7495
dc.contributor.orcid0000-0001-5777-1066
dc.contributor.orcid0000-0002-1521-7793
dc.date.accessioned2025-11-13T09:49:17Z
dc.date.issued2023-09-29
dc.identifier.doihttps://doi.org/10.1097/md.0000000000035394
dc.identifier.endpagee35394
dc.identifier.issn0025-7974
dc.identifier.issue39
dc.identifier.openalexW4387165361
dc.identifier.startpagee35394
dc.identifier.urihttps://hdl.handle.net/11421/2291
dc.identifier.urihttps://doi.org/10.1097/md.0000000000035394
dc.identifier.volume102
dc.language.isoen
dc.relation.ispartofMedicine
dc.rightsopenAccess
dc.subjectExenatide
dc.subjectMedicine
dc.subjectInternal medicine
dc.subjectEndocrinology
dc.subjectBone remodeling
dc.subjectBone mineral
dc.subjectInsulin glargine
dc.subjectBone resorption
dc.subjectOsteoprotegerin
dc.subjectRANKL
dc.subjectLiraglutide
dc.subjectType 2 Diabetes Mellitus
dc.subjectN-terminal telopeptide
dc.subjectType 2 diabetes
dc.subjectOsteoporosis
dc.subjectDiabetes mellitus
dc.subjectReceptor
dc.subjectAlkaline phosphatase
dc.subjectOsteocalcin
dc.subjectActivator (genetics)
dc.subjectChemistry
dc.subject.sdg3
dc.titleThe effects of exenatide and insulin glargine treatments on bone turnover markers and bone mineral density in postmenopausal patients with type 2 diabetes mellitus
dc.typeArticle
dspace.entity.typePublication
local.authorid.openalexA5001743294

Dosyalar

Koleksiyonlar

Publications